Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Kits Eyecare's Enterprise Value for the quarter that ended in Mar. 2026 was $345.0 Mil.
Kits Eyecare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kits Eyecare EV-to-EBIT Related Terms
Kits Eyecare EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Kits Eyecare's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Retail subindustry, Kits Eyecare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kits Eyecare EV-to-EBIT vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Kits Eyecare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Kits Eyecare's EV-to-EBIT falls into.
Kits Eyecare's current Enterprise Value is $307.2 Mil.
Kits Eyecare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kits Eyecare (KTYCF) has a EV-to-EBIT of 59.23 as of Jul. 20, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Kits Eyecare and its competitors. According to the industry distribution chart, Kits Eyecare ranks #812 out of 874 companies in the Retail - Cyclical industry, placing it in the top 92.9%.
Is Kits Eyecare's EV-to-EBIT too high?
Kits Eyecare's current EV-to-EBIT is 59.23. The Retail - Cyclical industry median EV-to-EBIT is 13.49. Kits Eyecare's value of 59.23 is 339.2% above this industry median. Based on the distribution chart, Kits Eyecare ranks #812 out of 874 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Kits Eyecare has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kits Eyecare's EV-to-EBIT compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Kits Eyecare ranks #812 out of 874 companies for EV-to-EBIT. This places Kits Eyecare in the lower half of its industry. The industry median EV-to-EBIT is 13.49. Kits Eyecare's value of 59.23 is 339.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Retail - Cyclical company?
The median EV-to-EBIT among Retail - Cyclical companies is 13.49, based on 874 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kits Eyecare's current EV-to-EBIT of 59.23 is 339.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Kits Eyecare and its competitors. For the Retail - Cyclical industry, the median EV-to-EBIT is 13.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kits Eyecare's current EV-to-EBIT is 59.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kits Eyecare stock overvalued right now?
Based on GuruFocus' analysis, Kits Eyecare (KTYCF) is currently considered Fairly Valued. The stock's GF Value™ is $9.64, compared to a current price of $9.51 — trading 1.3% below its estimated fair value. The current EV-to-EBIT is 59.23 and 339.2% above the Retail - Cyclical industry median of 13.49. Kits Eyecare's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Kits Eyecare (KTYCF), the current EV-to-EBIT is 59.23 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kits Eyecare (KTYCF) Overvalued in 2026?
Based on GuruFocus' analysis, Kits Eyecare stock appears to be undervalued.
The current stock price of $9.51 is trading 1.3% below its estimated GF Value™ of $9.64.
GuruFocus considers Kits Eyecare to be Fairly Valued.
Key valuation signals for KTYCF:
EV-to-EBIT: 59.23
GF Value™: $9.64 vs. price of $9.51 (1.3% below fair value)
Industry Position: 339.2% above the Retail - Cyclical median (#812 of 874)
No single metric tells the full story. See the KTYCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kits Eyecare Ltd is a vertically integrated, digitally native eyecare platform that offers its customers access to a vast selection of the highest quality contact lenses and eyeglasses, including its exclusive KITS-designed products, and a suite of online vision tools. It operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. The company's contact lens partners include Alcon, Bausch & Lomb, CooperVision, and Johnson & Johnson, and its glasses partners include Gucci, Oakley, Prive Revaux, Ray-Ban and Tom Ford. Its geographic locations are the United States; and Canada and Other which generates the majority of its revenue from the United States.
74GF Score
Get the complete analysis for KTYCF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KTYCF has been successfully added to your 
